NCT05011760View on ClinicalTrials.gov

[C-11]NPA PET-amphetamine in Cocaine Use Disorders

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

January 31, 2021

Primary Completion Date

September 1, 2028

Study Completion Date

September 1, 2028

Conditions

Cocaine Use Disorder

Interventions

RADIATION

Baseline [C-11]NPA PET Scan

Radiotracer

DRUG

d-amphetamine

Oral, 0.5 mg/Kg

RADIATION

Post-amphetamine [C-11]NPA PET Scan

Radiotracer

Trial Locations (1)

15213

RECRUITING

University of PIttsburgh, Pittsburgh

All Listed Sponsors

collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Rajesh Narendran

OTHER